NEW YORK (Reuters) - Some major hospitals are switching from using a heparin blood thinner product made by Baxter International Inc (BAX.N: Quote, Profile, Research) to one produced by its rival APP Pharmaceuticals Inc APPX.O, the Wall Street Journal reported on Tuesday.
